Equity indices trimmed initial losses in morning trade. The Nifty regained the crucial 17,000 mark after hitting the low of 16,928.60 in early trade. Barring banks and auto shares, selling pressure was seen across the board.
At 10:21 IST, the barometer index, S&P BSE Sensex declined 408.65 points or 0.71% at 56,788.13. The Nifty 50 index fell 153.9 points or 0.9% at 17,018.65.
The broader market traded with losses. The S&P BSE Mid-Cap index fell 1.32% while the S&P BSE Small-Cap index declined 1.16%.
The market breadth, indicating the overall health of the market, was weak. On the BSE, 959 shares rose while 2,244 shares fell.
A total of 132 shares were unchanged.
Results Today:
Century Textiles and Industries (up 1.04%), Eveready Industries (down 0.88%), Gujarat Mineral Development (up 1.39%), Mahindra CIE Automotive (up 6.34%), Tatva Chintan Pharma Chem (up 1.09%), Tata Investment (down 0.67), Steel Exchange India (up 0.26%), Meghmani Finechem (down 0.14%), Maharashtra Scooters (up 0.21%), Triveni Enterprises (up 3.26%) and Snowman Logistics (down 1.18%) will announce their financial results today.
Buzzing Index:
The Nifty Metal index slipped 3% to 6,247.75, extending its losing run to second consecutive trading session. The metal index has declined nearly 5% in two days.
NMDC (down 4.79%), Hindustan Zinc (down 4.49%), Jindal Steel & Power (down 4.22%), Steel Authority of India (down 4.14%) and National Aluminium Company (down 4.08%) were the top losers. Among the other losers were Tata Steel (down 3.93%), JSW Steel (down 3.65%), Vedanta (down 3.08%), Jindal Stainless (Hisar) (down 2.78%) and Welspun Corp (down 2.76%).
Stocks in Spotlight:
Glenmark Pharmaceuticals fell 1.69%. The drug maker launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with Pioglitazone for type 2 diabetes in India. The drug will increase the accessibility of quality drug for effective diabetes management.
Central Bank of India slipped 0.77% to Rs 19.45 after the bank said that the Reserve Bank of India had imposed a penalty of Rs 36 lakh for non-compliance with certain directions issued by the country's banking regulator. The directions pertain to 'Customer Protection - Limiting Liability of Customers in Unauthorised Electronic Banking Transactions'. "This action is based on the deficiencies in regulatory compliance and is not intended to pronounce upon the validity of any transaction or agreement entered into by the bank with its customers, the RBI said in a statement.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU